Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-008064
Filing Date
2023-03-10
Accepted
2023-03-10 16:30:15
Documents
1
Period of Report
2023-03-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6383
  Complete submission text file 0000899243-23-008064.txt   8342
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Issuer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7372 Services-Prepackaged Software

Mailing Address C/O ENFUSION INC. 125 SOUTH CLARK ST. STE. 750 CHICAGO IL 60603
Business Address
Hammoud Tarek (Reporting) CIK: 0001880790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40949 | Film No.: 23724103

Mailing Address C/O ENFUSION, INC. 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address C/O ENFUSION, INC. 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 312-253-9800
LRA Ventures, LLC (Reporting) CIK: 0001912134 (see all company filings)

State of Incorp.: FL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40949 | Film No.: 23724102